Dishman Carbogen Amcis Limited

NSE:DCAL.NS

256.4 (INR) • At close July 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202520242023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 27,11525,436.223,150.521,406.819,120.320,43619,199.316,52717,136.915,960.515,887.413,852.48212,722.17811,241.32210,313.559,153.57410,623.5788,030.7625,785.722,774.3981,864.22
Cost of Revenue 5,016.524,017.65,342.14,588.84,840.916,678.315,29413,003.112,826.311,150.65,540.33,780.9433,800.988,409.7624,494.833,573.6434,034.2563,506.1212,535.611,520.3781,415.027
Gross Profit 22,098.51,418.617,808.416,81814,279.43,757.73,905.33,523.94,310.64,809.910,347.110,071.5398,921.1982,831.565,818.725,579.9316,589.3224,524.6413,250.111,254.02449.193
Gross Profit Ratio 0.8150.0560.7690.7860.7470.1840.2030.2130.2520.3010.6510.7270.7010.2520.5640.610.620.5630.5620.4520.241
Reseach & Development Expenses 0129.8013965215.5137.752.452.905.72811.4992.7083.2860000000
General & Administrative Expenses 01,144.21,003.4721.6630.9557.6731.3495.7613.6493.6405.9321.249265.464307.261987.4191,001.5761,244.61841.959689.651262.8580
Selling & Marketing Expenses 0248354.7294.4219.423451.412.7127.374.7147.7133.425129.39395.81308.5050-0.002000
SG&A 4,443.51,392.21,358.11,016850.3791.6782.7508.4740.9568.3553.6454.674394.8571,251.714987.4191,010.0811,244.61841.957689.651262.8580
Other Expenses 20,346.5157.115,395.415,364.513,487.61070020.811,933.409,605.3666,420.0520.2053,089.3944,569.855,344.7123,682.6842,560.459991.16224.266
Operating Expenses 20,346.519,404.916,753.516,519.514,402.915,679.97,855.76,818.56,548.812,501.70.04110,071.5396,817.6177,370.3914,076.8135,579.9316,589.3224,524.6413,250.111,254.0224.266
Operating Income 1,752-478.61,054.9298.5-123.52,331.33,356.32,513.82,476.73,025.31,745.4622,284.9082,108.6091,517.2191,343.3591,712.9611,975.71,056.673888.011527.442424.927
Operating Income Ratio 0.065-0.0190.0460.014-0.0060.1140.1750.1520.1450.190.110.1650.1660.1350.130.1870.1860.1320.1530.190.228
Total Other Income Expenses Net -1,558.9-744-1,600.8-341-526.8-359.3-268.4-205.9-315.9-691.7-153.477-720.885-656.174-638.1-435.619-387.673-401.144171.77870.66517.719-84.912
Income Before Tax 193.1-1,222.6-545.9-42.5-650.31,9723,087.92,307.92,160.82,333.61,591.9851,564.0231,452.435879.119907.741,325.2881,574.5561,228.451958.676545.161340.015
Income Before Tax Ratio 0.007-0.048-0.024-0.002-0.0340.0960.1610.140.1260.1460.10.1130.1140.0780.0880.1450.1480.1530.1660.1960.182
Income Tax Expense 160.7311.9-247.9-222.61,001386.9984.6762.2706.5623.6394.381471.3449.903311.534107.62149.525103.91310.87929.55930.21914.286
Net Income 32.4-1,534.5-298180.1-1,651.31,585.12,103.31,545.71,454.31,711.11,198.091,092.7221,002.939567.585800.121,175.7631,461.9111,197.068917.09508.445325.729
Net Income Ratio 0.001-0.06-0.0130.008-0.0860.0780.110.0940.0850.1070.0750.0790.0790.050.0780.1280.1380.1490.1590.1830.175
EPS 0.21-9.79-1.91.15-10.539.8513.039.589.0110.67.436.776.223.524.967.289.077.856.583.72.4
EPS Diluted 0.21-9.79-1.91.15-10.539.8513.039.589.0110.67.436.776.223.524.967.228.997.355.663.162.4
EBITDA 4,725.13,071.83,076.23,425.62,864.25,249.35,976.94,908.34,680.44,368.63,996.183,570.1833,079.0262,252.3482,152.7072,307.1212,617.0281,528.6921,154.25649.75538.213
EBITDA Ratio 0.1740.1210.1330.160.150.2570.3110.2970.2730.2740.2520.2580.2420.20.2090.2520.2460.190.1990.2340.289